Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Stock of Zimmer Biomet Holdings, Inc. (ZBH) Ranked a Sell

The current recommendation of Sell for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is computed using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 2 months.

Buy Recommendation for Baxter International (BAX) Maintained

The current recommendation of Buy for Baxter International Inc (NYSE:BAX) is computed using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 9 months.

Buy Ranking for Koninklijke Philips (PHG) Retained

The current recommendation of Buy for Koninklijke Philips NV (NYSE:PHG) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. PHG has maintained this ranking for 2 months.

Strong Buy Ranking on Intuitive Surgical (ISRG) Shares Retained

Intuitive Surgical Inc (NASDAQ:ISRG) is ranked as a Strong Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking ISRG has had from Portfolio Grader for 6 months.

Hold Ranking for Boston Scientific (BSX) Stock Maintained

Portfolio Grader currently ranks Boston Scientific (NYSE:BSX) a Hold. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. BSX has maintained this ranking for 2 months.

Buy Rating on Becton Dickinson & Co (BDX) Shares Kept

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. The approach to investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Stryker Corporation (SYK) Stock Rated a Strong Buy

Stryker Corporation (NYSE:SYK) is ranked as a Strong Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. SYK has maintained this ranking for 2 months.

Analysts Keep Danaher Corporation (DHR) Sell Rating

The current recommendation of Sell for Danaher Corporation (NYSE:DHR) is derived using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Abbott Laboratories (ABT) Raised to Buy from a Hold

Portfolio Grader currently ranks Abbott Laboratories (NYSE:ABT) a Buy. Using Louis Navellier's investing approach, this analytical tool researches stocks with fundamental and quantitative analytical tools. ABT has been upgraded from a Hold to a Buy in the last week.

Banco Santander’s (SAN) Shares Have Strong Buy Recommendation Reaffirmed

Currently, Banco Santander SA (NYSE:SAN) has a Strong Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Buy Rating on Toronto-Dominion Bank (TD) Shares Kept

Toronto-Dominion Bank (NYSE:TD) is ranked as a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Sell Recommendation for Medtronic (MDT) Shares Retained

Currently, Medtronic Plc (NYSE:MDT) has a Sell using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Why Tesla Inc (TSLA) Stock Is STILL Just a Gamble Right Now

TSLA stock is a speculative bet due to Tesla's high valuation and production delays on its innovative technologies.

Royal Bank of Canada (RY) Stock Keeps Buy Rating

Currently, Royal Bank of Canada (NYSE:RY) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. RY has maintained this ranking for 4 months.

HSBC Holdings plc Sponsored ADR (HSBC) Rating Declines to Buy

HSBC Holdings plc Sponsored ADR (NYSE:HSBC) is ranked as a Buy using Louis Navellier's investing system and his Portfolio Grader stock evaluator. The shares have been downgraded from a Strong Buy to a Buy in the last week.

Buy Recommendation for Citigroup (C) Kept

The current recommendation of Buy for Citigroup Inc (NYSE:C) is derived using Louis Navellier's investing system and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking C has had from Portfolio Grader for the last month.

Bank of America’s (BAC) Buy Rating Affirmed

The current recommendation of Buy for Bank of America Corp (NYSE:BAC) is the result of using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. BAC has maintained this ranking for 2 months.

Shares of Wells Fargo & Co (WFC) Downgraded From a Hold to Sell

Portfolio Grader currently ranks Wells Fargo & Co (NYSE:WFC) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The shares have been downgraded from a Hold to a Sell in the last week.

JPMorgan Chase & Co (JPM) Retains Buy Ranking

The current recommendation of Buy for JPMorgan Chase & Co (NYSE:JPM) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. JPM has maintained this ranking for 3 months.